Dipexium Pharmaceuticals: Could They Benefit From The Antibiotic Resistance War? Seeking Alpha, 16 Apr 2016 Dipexium Pharmaceuticals (NASDAQ: DPRX ) is a micro-cap biopharmaceutical company with market capitalization of about $100…